{
  "slug": "depression-lifetime",
  "question": "What are the odds of experiencing a major depressive episode in your lifetime?",
  "category": "health",
  "tags": [
    "mental-health"
  ],
  "no_reliable_estimate": false,
  "perceived": {
    "description": "There is no standard tracker for perceived lifetime depression risk, and the question is awkwardly reflexive — asking someone to estimate their own probability of a condition partially defined by distorted self-perception. When lifetime prevalence figures are surfaced in surveys, most respondents express surprise at the 1-in-5 number. The lay mental model places \"clinical depression\" as something that happens to a distinct minority — perhaps 5-10% of the population — rather than to a fifth of all adults. Stigma compresses the intuitive estimate downward; so does the ordinary human tendency to classify one's own past low periods as \"just being sad\" rather than as episodes that would meet diagnostic criteria.\n",
    "rough_estimate": "most adults would guess 5-10% lifetime, roughly half the actual figure",
    "kind": "intuition"
  },
  "native": {
    "display": "20.6% lifetime prevalence (DSM-5 MDD, NESARC-III)",
    "numerator": 206,
    "denominator": 1000,
    "unit": "lifetime prevalence",
    "population": "US adults 18+, noninstitutionalized civilian (NESARC-III, 2012-2013)"
  },
  "normalized": {
    "lifetime_us_adult": 0.206,
    "display": "~1 in 5 lifetime",
    "log_value": -0.686,
    "assumptions": "Uses the Hasin et al. 2018 NESARC-III estimate of 20.6% lifetime prevalence of DSM-5 major depressive disorder among US adults as the headline figure. This is a direct survey-based lifetime prevalence — no compounding or hazard conversion required. The earlier NCS-R (Kessler et al. 2003) found 16.2% lifetime under DSM-IV criteria; the upward shift reflects both the DSM-5 bereavement-exclusion removal and secular trends in reporting and detection. NIMH reports that 21.0 million US adults (8.3%) had at least one major depressive episode in the past year (NSDUH 2021), consistent with the lifetime figure given recurrence and recovery patterns. The 0.206 point estimate is bracketed by the NCS-R lower bound (~0.16) and prospective-cohort estimates that place lifetime risk as high as 0.30 when accounting for recall bias in retrospective surveys (Moffitt et al. 2010 Dunedin cohort). Uncertainty band 0.16–0.30 reflects this methodological range.\n",
    "uncertainty": {
      "low": 0.16,
      "high": 0.3
    },
    "scope": "us_adult_lifetime"
  },
  "sources": [
    {
      "url": "https://pubmed.ncbi.nlm.nih.gov/29450462/",
      "title": "Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States",
      "publisher": "JAMA Psychiatry (Hasin DS, Sarvet AL, Meyers JL, et al.)",
      "source_type": "peer_reviewed",
      "statistic": "Lifetime prevalence of DSM-5 MDD: 20.6% overall; 26.1% women, 14.7% men; 12-month prevalence 10.4% overall",
      "excerpt": "\"Of the 36,309 participants, the lifetime and 12-month prevalences of DSM-5 MDD were 20.6% (SE, 0.4) and 10.4% (SE, 0.3), respectively... Lifetime prevalence was 26.1% among women and 14.7% among men. Most lifetime MDD cases were moderate (39.7%) or severe (49.5%).\"\n",
      "source_date": "2018-04-01",
      "source_accessed": "2026-04-19",
      "archive_url": "http://web.archive.org/web/20260405112357/https://pubmed.ncbi.nlm.nih.gov/29450462/",
      "calculation_notes": "NESARC-III is a nationally representative face-to-face survey of 36,309 US civilian noninstitutionalized adults aged 18+ conducted April 2012 to June 2013. Lifetime prevalence of 20.6% is used directly as the normalized figure — no hazard compounding needed because this is already a lifetime estimate. The women-to-men ratio of 26.1%/14.7% ≈ 1.78 provides the female multiplier of ~1.7. DSM-5 criteria were applied retrospectively; the removal of the DSM-IV bereavement exclusion slightly inflates prevalence relative to the earlier NCS-R estimate.\n",
      "independence_note": "NESARC-III (NIAAA/NIH) is an independent nationally representative survey with its own sampling frame, field operations, and diagnostic instrument (AUDADIS-5). Fully independent from the NCS-R (Harvard/NIMH) and from NSDUH (SAMHSA).\n"
    },
    {
      "url": "https://pubmed.ncbi.nlm.nih.gov/12813115/",
      "title": "The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)",
      "publisher": "JAMA (Kessler RC, Berglund P, Demler O, et al.)",
      "source_type": "peer_reviewed",
      "statistic": "Lifetime prevalence of major depressive disorder: 16.2% (95% CI 15.1-17.3); 12-month prevalence 6.6% (95% CI 5.9-7.3)",
      "excerpt": "\"The lifetime prevalence of DSM-IV MDD was 16.2% (95% confidence interval [CI], 15.1%-17.3%), representing approximately 32.6 to 35.1 million US adults... the 12-month prevalence was 6.6% (95% CI, 5.9%-7.3%), representing 13.1 to 14.2 million US adults.\"\n",
      "source_date": "2003-06-18",
      "source_accessed": "2026-04-19",
      "archive_url": "http://web.archive.org/web/20260425050106/https://pubmed.ncbi.nlm.nih.gov/12813115/",
      "calculation_notes": "NCS-R is a face-to-face household survey of 9,090 respondents aged 18+ conducted 2001-2002 across the 48 contiguous US states. The 16.2% figure under DSM-IV criteria is the lower bound of the uncertainty range. The gap between NCS-R (16.2%) and NESARC-III (20.6%) partly reflects DSM-5 bereavement-exclusion removal, partly secular trend, and partly methodological differences in diagnostic interview instruments (CIDI vs AUDADIS-5).\n",
      "independence_note": "NCS-R (Harvard/NIMH, Kessler) and NESARC-III (NIAAA, Hasin) are fully independent epidemiologic surveys with different sampling frames, field operations, and diagnostic instruments. Agreement to within 4 percentage points across different DSM editions and a decade apart is the strongest cross-validation available for US MDD prevalence.\n"
    },
    {
      "url": "https://www.nimh.nih.gov/health/statistics/major-depression",
      "title": "Major Depression — Statistics",
      "publisher": "National Institute of Mental Health (NIMH), NIH",
      "source_type": "govt_report",
      "statistic": "An estimated 21.0 million US adults (8.3%) had at least one major depressive episode in the past year (2021); highest among 18-25 year olds (18.6%); females (10.3%) vs males (6.2%)",
      "excerpt": "\"An estimated 21.0 million adults in the United States had at least one major depressive episode. This number represented 8.3% of all U.S. adults... The prevalence of major depressive episode was higher among adult females (10.3%) compared to males (6.2%).\"\n",
      "source_date": "2021-12-31",
      "source_accessed": "2026-04-19",
      "archive_url": "https://web.archive.org/web/20260411033541/https://www.nimh.nih.gov/health/statistics/major-depression",
      "calculation_notes": "NIMH republishes SAMHSA NSDUH data. The 8.3% past-year prevalence is consistent with the NESARC-III 12-month prevalence of 10.4% (NSDUH uses a screening instrument rather than a full diagnostic interview, which tends to yield slightly different estimates). The 21 million figure is the annual incidence/recurrence count; lifetime accumulation of this annual flow is what produces the 20.6% lifetime prevalence in the NESARC-III cohort study. Used as the federal government cross-check on the peer-reviewed lifetime figures.\n",
      "independence_note": "NSDUH (SAMHSA) is a separate survey from both NESARC-III and NCS-R, with its own sampling design and screening instrument. The past-year estimate is consistent with but methodologically independent of the lifetime prevalence figures above.\n"
    },
    {
      "url": "https://www.who.int/news-room/fact-sheets/detail/depression",
      "title": "Depressive disorder (depression) — fact sheet",
      "publisher": "World Health Organization",
      "source_type": "govt_report",
      "statistic": "An estimated 3.8% of the global population experiences depression; 5% of adults globally; higher among women (6.9%) than men (4.6%)",
      "excerpt": "\"An estimated 3.8% of the population experience depression, including 5% of adults... Depression is about 50% more common among women than among men. Worldwide, more than 10% of pregnant women and women who have just given birth experience depression.\"\n",
      "source_date": "2023-03-31",
      "source_accessed": "2026-04-19",
      "archive_url": "https://web.archive.org/web/20260420034808/https://www.who.int/news-room/fact-sheets/detail/depression",
      "calculation_notes": "WHO reports point prevalence (proportion affected at any given time), not lifetime prevalence. The 5% adult point prevalence globally is consistent with US 12-month figures of 6.6-10.4% given that many episodes last less than a year and global detection rates are lower. Used here as the international cross-check on depression burden magnitude, not as the primary lifetime estimate.\n",
      "independence_note": "WHO depression estimates derive from the Global Burden of Disease study (IHME) and WHO's own mental health surveys — fully independent from the US-based NESARC-III, NCS-R, and NSDUH pipelines.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "Cancer death (lifetime, global adult)",
      "lifetime_us_adult": 0.14
    },
    {
      "label": "Type 2 diabetes death (lifetime, US adult)",
      "lifetime_us_adult": 0.025
    },
    {
      "label": "Suicide (lifetime, US adult)",
      "lifetime_us_adult": 0.00827
    },
    {
      "label": "Alzheimer's disease (lifetime, US adult)",
      "lifetime_us_adult": 0.107
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "Female",
      "multiplier": 1.7,
      "notes": "NESARC-III lifetime prevalence: 26.1% women vs 14.7% men, ratio ≈ 1.78. Rounded to 1.7 as a conservative multiplier. The gender gap is one of the most replicated findings in psychiatric epidemiology."
    },
    {
      "factor": "Age 18-25",
      "multiplier": 1.5,
      "notes": "NIMH NSDUH data shows 18.6% past-year prevalence among 18-25 year olds vs 8.3% population average; the elevated rate partly reflects first-onset concentration in early adulthood."
    },
    {
      "factor": "History of childhood adversity (4+ ACEs)",
      "multiplier": 2,
      "notes": "Meta-analyses of adverse childhood experiences consistently find OR ≈ 2.0-2.1 for adult depression among those with multiple ACEs (neglect, abuse, household dysfunction). Dose-response relationship is well established."
    },
    {
      "factor": "First-degree family history of MDD",
      "multiplier": 2.8,
      "notes": "Offspring of parents with MDD carry approximately 2-3x the risk of lifetime MDD; twin-study heritability estimates for MDD are 30-40%."
    },
    {
      "factor": "Strong social support network",
      "multiplier": 0.5,
      "notes": "Protective factor. Prospective cohort studies consistently find roughly halved depression incidence among adults with robust social integration vs those who are socially isolated."
    },
    {
      "factor": "Male",
      "multiplier": 0.7,
      "notes": "14.7% male lifetime prevalence vs 20.6% overall in NESARC-III; ratio ≈ 0.71."
    }
  ],
  "short_label": "Major depression",
  "myth_framing": "underrated",
  "outcome_severity": "serious_harm",
  "exposure_pattern": "recurring",
  "outcome_type": "mental_trauma",
  "valence": "negative",
  "caveats": "\"Major depressive episode\" is defined by DSM-5 criteria: five or more symptoms during a two-week period, including depressed mood or loss of interest/pleasure, representing a change from previous functioning. The lifetime prevalence figure captures anyone who has ever met these criteria, not current cases. Retrospective surveys undercount lifetime episodes because people forget or reframe past episodes — the Dunedin longitudinal cohort (Moffitt et al. 2010) found prospective lifetime prevalence approaching 30% by age 32, suggesting the 20.6% NESARC-III figure is likely a floor. Conversely, survey-based diagnostic instruments may overcount mild episodes that a clinician would not diagnose. The 12-month prevalence (8-10% of US adults) is the more policy-relevant number for treatment-capacity planning; the lifetime figure is the right one for answering \"how common is this, really?\" Depression is treatable: roughly 60% of US adults with a past-year episode received some form of treatment in 2021 per NIMH, though treatment adequacy varies widely.\n",
  "quality_score": {
    "d1": 5,
    "d2": 5,
    "d3": 5,
    "d4": 5,
    "d5": 5,
    "d6": 5,
    "d7": 4,
    "d8": 5,
    "avg": 4.875,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-05-25",
    "methodology_version": "1.2"
  },
  "reviewer": "quality-review-agent",
  "last_reviewed": "2026-04-19",
  "reviewed": true,
  "generated_at": "2026-04-19",
  "image": {
    "alt": "A single chair facing a window with muted grey light filtering through, flat vector illustration in subdued tones."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/depression-lifetime"
}